Chinese-owned Gland Pharma re-appoints Srinivas Sadu as MD & CEO

Gland Pharma reported revenues of Rs 3463 and a net profit of Rs 997 crore in FY21. Shares of Gland Pharma rose 1.89% to close at Rs 3360 on BSE on Thursday, the benchmark Sensex gained 1.50% to 55,464.39 points.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/Vk3l4Io
via IFTTT